Efficacy and safety of the weight-loss drug rimonabant

Lancet. 2008 Feb 16;371(9612):555; author reply 556-7. doi: 10.1016/S0140-6736(08)60261-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Obesity Agents / adverse effects*
  • Depression / chemically induced
  • Depressive Disorder, Major
  • Humans
  • Obesity / drug therapy*
  • Obesity / psychology
  • Patient Selection
  • Piperidines / adverse effects*
  • Pyrazoles / adverse effects*
  • Rimonabant
  • Suicide

Substances

  • Anti-Obesity Agents
  • Piperidines
  • Pyrazoles
  • Rimonabant